Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.

Source:http://linkedlifedata.com/resource/pubmed/id/12065557

J. Clin. Oncol. 2002 Jun 15 20 12 2805-11

Download in:

View as

General Info

PMID
12065557